The Claim
Oral melatonin supplementation significantly improves endothelial function, as measured by flow-mediated dilation, in non-diabetic patients with heart failure with reduced ejection fraction, whereas it provides no significant benefit in diabetic patients, indicating that melatonin's vascular protective effects are modulated by underlying metabolic status and glucose regulation.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking melatonin supplements helps improve blood vessel health in heart failure patients who don't have diabetes, but it doesn't seem to help those who do have diabetes. This suggests that a person's blood sugar levels might change how well melatonin works to protect the heart and blood vessels.
See the scientific wording
Oral melatonin supplementation significantly improves endothelial function, measured by flow-mediated dilation (FMD), in non-diabetic patients with heart failure with reduced ejection fraction, but shows no significant benefit in diabetic patients. This differential effect suggests that melatonin's vascular protective properties may be modulated by underlying metabolic status, specifically glucose regulation.
What the research says
1 studyThe study shows melatonin improves blood vessel function in heart failure patients overall, but it does not test whether diabetes changes this effect, so it cannot confirm the claim's specific details about diabetic versus non-diabetic patients.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.